Expanding collaborative endeavors, utilizing the production of "Sputnik V" as a case study, is a proposal put forth by Tokayev.
FosteringMore: Kazakhstan's Proposal to Expand Cooperation Beyond Vaccine Production in EAEU Countries.
Kazakhstan's President Kassym-Jomart Tokayev proposes extending scientific-industrial collaborations, inspired by their partnership in producing the Sputnik V vaccine, to other industries within the Eurasian Economic Union (EAEU). This proposition was made at a meeting of the Supreme Eurasian Economic Council, as reported by Total.kz.
According to Tokayev, Russia's collaboration in establishing vaccine production within Kazakhstan represents a significant success story in scientific-industrial cooperation. He emphasizes that this model can be expanded across other industries.
The President indicated that Kazakhstan is making every effort to reduce disease prevalence among its population, mainly through mass vaccinations. In addition to QazVac, Kazakhstan's homegrown vaccine, the country has participated in the production of Sputnik V.
Tokayev underlined that, given the seasonal nature of the disease, continuous cooperation and collaboration in immunization efforts are crucial. He expressed his belief that such cooperation will be essential in combating the virus.
Underlying this cooperation is the technology transfer for vaccine production and associated capacity building within the pharmaceutical industry. This collaboration has the potential to enhance the manufacturing capabilities and expertise in biotechnology and pharmaceuticals across EAEU member states, including Kazakhstan.
Potential economic and industrial impacts of this cooperation include economic growth, improved supply chains, and diversification into related sectors. The growth of the pharmaceutical sector could generate new jobs and investment opportunities, while the establishment of robust supply chains could benefit other industries. Furthermore, the skills and infrastructure developed through vaccine production could pave the way for diversification into other biotech or medical device manufacturing sectors.
Though specific instances of the Sputnik V production impacting other industries in Kazakhstan are scarce, the general trends suggest that similar collaborations could foster broader economic and industrial development within the region. As a major player in the EAEU, Kazakhstan might capitalize on broader regional growth in pharmaceuticals and biotechnology, potentially fueling advancements in other sectors relying on similar technologies or infrastructure.
- Kazakhstan's President, Kassym-Jomart Tokayev, suggests that the successful collaboration in the medical-conditions sector, specifically vaccine production, can be extended to other industries within the Eurasian Economic Union (EAEU), such as health-and-wellness, biotechnology, and pharmaceuticals, including the use of CBD for various health purposes, given the potential for economic growth and industrial diversification.
- The President of Kazakhstan, Tokayev, proposes that the finance industry could be further integrated into this scientific-industrial collaboration, considering the potential for increased investment opportunities and economic growth in the health-and-wellness, biotechnology, and pharmaceutical industries, including the CBD sector.
3.Tokayev emphasizes that fostering cooperative relationships across various industries, such as science, medical-conditions, health-and-wellness, industry, CBD, and finance, could lead to advancements in the technology and infrastructure necessary for the production of vaccines and other life-saving medical treatments, benefiting not only Kazakhstan but also other EAEU member states.
